These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Autoantibodies in type 1 diabetes mellitus]. Ziegler M; Ziegler B Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261 [No Abstract] [Full Text] [Related]
26. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies. Franke B; Galloway TS; Wilkin TJ Diabetes Metab Res Rev; 2005; 21(5):395-415. PubMed ID: 15895384 [TBL] [Abstract][Full Text] [Related]
29. [Diagnostic value of serum islet autoantibody in hepatogenic diabetes mellitus]. Zhang L; Shi YL; Hong WX; Jia WD; Li LH Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1034-6. PubMed ID: 16864107 [TBL] [Abstract][Full Text] [Related]
30. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086 [TBL] [Abstract][Full Text] [Related]
31. [Islet autoantibody assays in type I diabetes: superiority of passage from use of ICA to traditional tests]. Lazar D; Weintrob N; Abramov N; Assa S; Bloch K; Ofan R; Ben-Zaken H; Vardi P Harefuah; 1998 May; 134(9):678-81, 750. PubMed ID: 10909610 [TBL] [Abstract][Full Text] [Related]
32. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients. Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671 [TBL] [Abstract][Full Text] [Related]
36. Screening for coeliac disease in families of adults with Type 1 diabetes based on serological markers. Matteucci E; Cinapri V; Quilici S; Lucchetti A; Mugnaini P; Giampietro O Diabetes Nutr Metab; 2001 Feb; 14(1):37-42. PubMed ID: 11345164 [TBL] [Abstract][Full Text] [Related]
37. Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildren. Kulmala P; Rahko J; Savola K; Vähäsalo P; Veijola R; Sjöroos M; Reunanen A; Ilonen J; Knip M Diabetologia; 2000 Apr; 43(4):457-64. PubMed ID: 10819239 [TBL] [Abstract][Full Text] [Related]
38. Role of insulin autoantibody affinity as a predictive marker for type 1 diabetes in young children with HLA-conferred disease susceptibility. Siljander H; Härkönen T; Hermann R; Simell S; Hekkala A; Salonsaari RT; Simell T; Simell O; Ilonen J; Veijola R; Knip M Diabetes Metab Res Rev; 2009 Oct; 25(7):615-22. PubMed ID: 19637309 [TBL] [Abstract][Full Text] [Related]
39. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children. Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935 [TBL] [Abstract][Full Text] [Related]
40. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]